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Introduction. The actuality of the studied subject is conditioned by the increase of the 
prevalence of gout. Gout arises following the deposition of uric acid crystals in joints as a 
consequence of hyperuricemia. Frequent co-morbidities, non-compliance of the patients to 
treatment and the contribution to other organ involvement: cardiovascular diseases, severe 
nephropathy, disability, all these are major problems that make gout control difficult. The drugs 
of choice for acute gouty arthritis are nonsteroidal anti-inflammatory drugs (NSAID), 
colchicine and corticosteroids. Treatment with xanthine oxidase inhibitors or uricosuric drugs 
is indicated for the long term and the end target is the value of uric acid <360 mcmol/l, and 
even 300 mcmol/L in patients with advanced tophaceous gout.   
Aim of the study. Analysis of uric acid lowering therapy, prophylactic treatment of gout flair-
ups and treatment strategy in acute gout attack.  
Materials and methods. A retrospective study was done on patients diagnosed with gout and 
hospitalized in the arthrology department of the Republican Clinical Hospital for the year 2018. 
In the number of 66 patients, 56 of the being males and 10 females, having average age - 58 
years.  
Results. It was found that the average age of the disease debut was 44 years for males and 52 
for females. Before hospitalization as the basic treatment 77% of the patients used allopurinol 
and 23% - febuxostat. 45% of them didn’t administer the treatment on a regular basis, among 
this group the average level of uric acid was 553 mcmol/l. On the other side, for the group 
which used to follow to treatment (55%) this indicator was 401 mcmol/l. In the hospital for the 
acute gout attack in 65% of cases NSAID were used, in 3% - colchicin and the other 29% - 
combined therapy (NSAID and colchicin). In 53% of cases intraarticular corticosteroids were 
used. As a basic treatment it was found that for the 83,4% was indicated allopurinol and for the 
16,6% febuxostat.  
Conclusions. I have found correlation between the level of uric acid and compliance with the 
treatment. Also studied treatment methods of gout depends on the stage of the disease, age of 
patient, and concomitant diseases.  
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Introduction. Osteoporosis is a disease where bones lose their bone mineral density (BMD) 
which causes bone fragility and leads to fractures, Rheumatoid arthritis (RA) is an autoimmune 
inflammatory disease that affects the joints symmetrically and is known to cause secondary 
osteoporosis  
Aim of the study. To study literatures that focus on the risk factors of osteoporosis and the 
correlation between it and rheumatoid arthritis.  
Materials and methods. A literature search using, PubMed, Medscape and the national 
scientific information archive was performed. among the most relevant articles we selected 70, 
the data were analyzed by content structure and summarized,as well as statistical analysis 
where possible .  
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Results. In patients with RA four biomarkers are found to predict fracture sites, Tartrate-
resistant acid phosphate 5b (TRACP-5b), undercarboxynated osteocalcin (Uc-OC) and bone 
specific alkaline phosphate (BAP) are able to realize both BMD and bone quality while 
homocysteine is able to realize only bone quality, In RA patients annual bone mineral density 
changes are 0.14 + 2.70 in lumbar spine, 0.46 + in proximal hip and 1.14 + 1.85 in forearm. 
Some studies show that in lumbar spine Homocysteine is the significant predictor for fractures, 
while in the proximal hip and forearm homocysteine does not have any significance. The most 
potent predictors for hip and forearm fractures are DAS28-ESR, blood pressure and Vitamin 
D levels other authors consider a better predictor to be ACPA and Methotrexate dosage use. 
Another hypothesis suggests that mycobacterium Avium Paratuberculosis (MAP) infection 
associated with TNF polymorphisms in patients with rheumatoid arthritis might cause 
secondary osteoporosis and it was found that the association between MAP infection in patients 
with rheumatoid arthritis and a risk for development of osteoporosis.  
Conclusions. Osteoporosis is a common condition diagnosed in patients with RA. Secondary 
osteoporosis due to RA depends on the disease activity, ACPA level, MTX dosage. Some 
biochemical markers, as homocysteine, TRACP-5b, Uc-OC and bone specific alkaline 
phosphate can serve as predictors for osteoporotic fractures at different sites  
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Introduction. With society trending towards aging and unhealthy lifestyle changes the 
prevalence rate of essential hypertension (EH) and osteoporosis (OP) increases every year, to 
a point where they have become the two most common diseases in the world.  
Aim of the study. To highlight the relationship between essential hypertension (EH) and bone 
mineral density (BMD).   
Materials and methods. A systematic review on the published literature was conducted. 17 
articles on the topic of association between EH and BMD were selected after searching 
PubMed, Medline, Medscape, and Google Scholar. The data were anaysed and statistically 
compared .  
Results. The 17 articles used have a total of 39,491patients. Of these, 13,375 were patients 
with EH and 26,116 were patients without EH. The most relevant meta-analysis results showed 
that EH can reduce the BMD of the lumbar spine (95% CI: −0.08∼0.01, P=0.006), femoral 
neck (95% CI: −0.09∼-0.02, p = 0.001), ward's triangle (95% CI: −0.45∼-0.25, p=0.000), 
femoral intertrochanteric (95% CI: −0.90∼-0.64, p = 0.000), calcaneus (95% CI: −0.31∼-0.18, 
p = 0.000) and distal forearm (95% CI: −0.09∼-0.03, p = 0.000), but EH cannot reduce the 
BMD of the femur rotor (95% CI: −0.07∼0.24, p = 0.273). Another valuable study showed that 
EH can reduce the BMD of the lumbar spine (95% CI: −0.11∼-0.03, p = 0.000) and femoral 
neck (95% CI: −0.11∼-0.07, p = 0.000) in Asian populations. In non-Asian populations, EH 
